Skip to Content

Continuing Education

Updates in CAR T-Cell Therapy for Multiple Myeloma

Best Suited For: Pharmacist

CE Credits: 0.5 hours

Related Topics: CAR T-Cell Therapy, Multiple Myeloma

Description

In this Podcast-style CE activity, we will provide updates on new indications for use of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma. This CE activity will include but is not limited to discussion on new indications for CAR T-Cell Therapy, toxicities related to specific CAR T-Cell products, and management of novel toxicities seen with CAR T-Cell products.

Pricing

This activity does not require payment to register.

This course has expired.

View our full list of NCODA courses or check the webinar recordings for more to discover.